Waters Corporation (WAT) DCF Valuation
Two independent models estimate Waters Corporation's fair value between $115.15 (conservative case) and $235.02 (analyst consensus).
What would today's price require?
$365.87 is justified only if free cash flow grows about +19.8% a year for the next decade — faster than the company has actually grown.
Current Price
$365.87
Fair-Value Range
$115.15 – $235.02
Market-Implied Growth
+19.8%/yr
vs -17.6% 5Y actual
WAT DCF Fair Value Calculator
Edit the assumptions to see how they change the estimated fair value. Illustrative model — not investment advice. Defaults to a conservative base case; the analyst (FMP) DCF, where available, is shown as a reference below.
Base inputs: FCF $507.5M · 0.07B shares · net debt $819.6M
Estimated Fair Value
$115.15
-68.5% vs $365.87
Sensitivity — fair value by discount rate × terminal growth
How the estimated fair value shifts with the discount rate (WACC) and terminal growth, holding your 5.0%/yr FCF growth and 10-year horizon fixed. Green = above today's $365.87; red = below. Your current case is outlined.
| WACC ↓ / Terminal → | 1.50% | 2.00% | 2.50% | 3.00% | 3.50% |
|---|---|---|---|---|---|
| 8.0% | $146 | $154 | $164 | $175 | $190 |
| 9.0% | $124 | $129 | $136 | $143 | $152 |
| 10.0% | $107 | $111 | $115 | $120 | $126 |
| 11.0% | $93.29 | $96.20 | $99.44 | $103 | $107 |
| 12.0% | $82.49 | $84.67 | $87.08 | $89.75 | $92.74 |
About Waters Corporation
Waters Corporation is a global leader in specialized measurement, delivering analytical solutions across Asia, the Americas, and Europe. The company operates through two main divisions: Waters and TA. Under its Waters segment, it engineers, manufactures, sells, and provides support for high and ultra-performance liquid chromatography and mass spectrometry (MS) systems. This includes essential consumables like chromatography columns and comprehensive post-warranty service plans. The TA segment focuses on designing, producing, selling, and servicing instruments for thermal analysis, rheometry, and calorimetry. Additionally, Waters develops and supplies sophisticated software that integrates with both its own instruments and those from other manufacturers. The company's advanced MS technology plays a crucial role in various applications, such as drug discovery and development (including clinical trial assessments), analyzing proteins involved in disease processes, ensuring nutritional safety, and conducting environmental testing. Its thermal analysis, rheometry, and calorimetry instruments are vital for assessing the suitability and stability of a wide range of materials, including fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids. These instruments support diverse sectors like industrial manufacturing, consumer goods, healthcare products, and life science research. Waters' extensive client base spans the life sciences, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental sectors, where its products are instrumental in research and development, quality assurance, and general laboratory operations. Established in 1958, Waters Corporation is headquartered in Milford, Massachusetts.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Udit Batra